Welcome to this week’s Women’s Health Weekly, a bite-sized round-up of some of the latest research, news and developments shaping women’s health.
This week, I’m looking at new research revealing how women with autoimmune conditions face greater barriers to diagnosis, a major study uncovering how menopause affects multiple systems throughout the body, and new findings exploring whether an existing medication could help reduce breast cancer risk after pregnancy.
IN THIS WEEK’S EPISODE
- Autoimmune conditions and misdiagnosis: what a study involving more than 6,600 people reveals about differences in how women’s and men’s symptoms are interpreted.
- Why women are more likely to have autoimmune symptoms attributed to psychological causes, and the impact of delayed diagnoses.
- Menopause and the body: what an analysis of more than 300 million laboratory tests reveals about biological changes around the final menstrual period.
- How menopause may involve more abrupt changes than previously understood, and what researchers discovered about menopausal hormone therapy.
- Breast cancer prevention: new research exploring whether cabergoline, a medication used to suppress milk production, could help reduce breast cancer risk after pregnancy.
- What researchers found in human health records and animal studies, and why clinical trials are needed before the medication can be considered for cancer prevention.
RESEARCH & FURTHER READING
Autoimmune Conditions & Gender Differences in Diagnosis
Research from the University of Cambridge and University of East Anglia examining differences in diagnostic experiences, psychological misdiagnosis and delays in treatment among people with autoimmune conditions.
Menopause & the Physiological Cliff
Nature Medicine - Population-scale research examining how menopause affects hormonal, skeletal, liver, kidney and metabolic systems, using more than 300 million laboratory tests.
Cabergoline & Breast Cancer Prevention
Cancer Discovery - Research investigating whether cabergoline, an existing medication used to suppress lactation, could reduce breast cancer risk following pregnancy, with further clinical trials planned.
FOLLOW & SUPPORT OWNING SPACE
Follow Owning Space wherever you’re listening so you don’t miss the next Women’s Health Weekly, released every Monday morning.
If you’re enjoying the podcast, please consider rating and reviewing the show. It helps more people discover these conversations.
For more conversations around women’s health, our bodies and the stories that deserve more space, follow @owningspacepodcast on Instagram and TikTok.
And if there’s a story, study or development you think I should cover in a future episode, or a subject you’d like me to explore in more depth, drop me a message.
Until next week, keep taking up space. 💛
#WomensHealth #AutoimmuneDisease #MenopauseResearch #BreastCancerAwareness #WomensHealthResearch
